KR880701564A - 스타버스트 콘쥬게이트 - Google Patents

스타버스트 콘쥬게이트

Info

Publication number: KR880701564A
Authority: KR; South Korea
Prior art keywords: starburst; dendrimer; starburst conjugate; conjugates; conjugate
Prior art date: 1986-08-18
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

KR1019880700411A

Other languages

English (en)

Other versions

KR970011151B1 (ko

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-08-18

Filing date

1988-04-18

Publication date

1988-11-03

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25407923&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR880701564(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1987-08-18 Application filed filed Critical

1988-11-03 Publication of KR880701564A publication Critical patent/KR880701564A/ko

1997-07-07 Application granted granted Critical

1997-07-07 Publication of KR970011151B1 publication Critical patent/KR970011151B1/ko

2007-08-18 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/08—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing solids as carriers or diluents
- A01N25/10—Macromolecular compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/595—Polyamides, e.g. nylon
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6883—Polymer-drug antibody conjugates, e.g. mitomycin-dextran-Ab; DNA-polylysine-antibody complex or conjugate used for therapy
- A61K47/6885—Polymer-drug antibody conjugates, e.g. mitomycin-dextran-Ab; DNA-polylysine-antibody complex or conjugate used for therapy the conjugate or the polymer being a starburst, a dendrimer, a cascade
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
- C08G69/48—Polymers modified by chemical after-treatment
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/02—Polyamines
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G83/00—Macromolecular compounds not provided for in groups C08G2/00 - C08G81/00
- C08G83/002—Dendritic macromolecules
- C08G83/003—Dendrimers
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L101/00—Compositions of unspecified macromolecular compounds
- C08L101/005—Dendritic macromolecules

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Polymers & Plastics (AREA)
Organic Chemistry (AREA)
Nanotechnology (AREA)
Biotechnology (AREA)
Toxicology (AREA)
Immunology (AREA)
Medical Informatics (AREA)
Molecular Biology (AREA)
Crystallography & Structural Chemistry (AREA)
Biophysics (AREA)
Agronomy & Crop Science (AREA)
Pest Control & Pesticides (AREA)
Plant Pathology (AREA)
General Engineering & Computer Science (AREA)
Dentistry (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Environmental Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Preparation (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Polyamides (AREA)
Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Luminescent Compositions (AREA)

KR1019880700411A 1986-08-18 1987-08-18 스타버스트 콘쥬게이트 Expired - Lifetime KR970011151B1 (ko)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US89745586A	1986-08-18	1986-08-18
US897,455		1986-08-18
PCT/US1987/002074 WO1988001178A1 (en)	1986-08-18	1987-08-18	Starburst conjugates

Publications (2)

Publication Number	Publication Date
KR880701564A true KR880701564A (ko)	1988-11-03
KR970011151B1 KR970011151B1 (ko)	1997-07-07

Family

ID=25407923

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
KR1019880700411A Expired - Lifetime KR970011151B1 (ko)	1986-08-18	1987-08-18	스타버스트 콘쥬게이트

Country Status (21)

Country	Link
EP (1)	EP0271180B2 (ko)
JP (6)	JPH0757736B2 (ko)
KR (1)	KR970011151B1 (ko)
AT (1)	ATE89743T1 (ko)
AU (2)	AU609051B2 (ko)
BR (3)	BR8707433A (ko)
DE (1)	DE3786000T3 (ko)
DK (1)	DK174053B1 (ko)
ES (1)	ES2054678T5 (ko)
FI (2)	FI103410B1 (ko)
GR (1)	GR3024215T3 (ko)
HK (1)	HK54396A (ko)
HU (2)	HU209252B (ko)
IE (1)	IE61356B1 (ko)
IL (1)	IL83567A (ko)
MX (1)	MX169992B (ko)
MY (1)	MY102878A (ko)
NO (1)	NO176306C (ko)
NZ (1)	NZ221484A (ko)
WO (3)	WO1988001180A1 (ko)
ZA (1)	ZA876114B (ko)

Families Citing this family (86)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5560929A (en) *	1986-08-18	1996-10-01	The Dow Chemical Company	Structured copolymers and their use as absorbents, gels and carriers of metal ions
US5914095A (en) *	1989-04-07	1999-06-22	Salutar, Inc.	Polychelants containg amide bonds
US5292868A (en) *	1989-05-26	1994-03-08	Akzo N.V.	Chelating agents for attaching metal ions to proteins
US5808003A (en) *	1989-05-26	1998-09-15	Perimmune Holdings, Inc.	Polyaminocarboxylate chelators
IE68411B1 (en) *	1989-05-26	1996-06-12	Akzo Nv	Chelating agents for attaching metal ions to proteins
DE3930674A1 (de) *	1989-09-11	1991-03-21	Diagnostikforschung Inst	Bifunktionelle chelatbildner zur komplexierung von tc- und re-isotopen, verfahren zu ihrer herstellung und darstellung von konjugaten daraus sowie deren verwendung in diagnostik und therapie
DE3938992A1 (de) *	1989-11-21	1991-05-23	Schering Ag	Kaskadenpolymer-gebundene komplexbildner, deren komplexe und konjugate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
AU642979B2 (en) *	1990-03-21	1993-11-04	Quest International B.V.	Utilization and delivery of enzymes
GB9021671D0 (en) *	1990-10-05	1990-11-21	Unilever Plc	Delivery of agents
AU642980B2 (en) *	1990-03-21	1993-11-04	Quest International B.V.	Ultilization of enzymes
AU641736B2 (en) *	1990-03-21	1993-09-30	Quest International B.V.	Delivery of agents
IL99234A (en) *	1990-08-27	1994-05-30	Michigan Molecular Inst	Non-cross-linked multi-branch polymers and their preparation
GB9112536D0 (en) *	1991-06-11	1991-07-31	Celltech Ltd	Chemical compounds
US5871713A (en) *	1991-12-04	1999-02-16	Guerbet S.A.	Macromolecular polyamine iodine-containing compound, process for its preparation and its use as a contrast agent
FR2688508A1 (fr) *	1992-03-13	1993-09-17	Guerbet Sa	Nouveau produit de contraste iode, son procede de preparation et son utilisation comme agent de contraste.
CA2125188A1 (fr) *	1991-12-04	1993-06-10	Dominique Meyer	Nouveau compose macromoleculaire polyamine iode, son procede de preparation et son utilisation comme agent de contraste
JPH07505915A (ja)	1992-04-14	1995-06-29	コーネル　リサーチ　ファウンデーション、インコーポレーテッド	樹枝状巨大分子およびその製造法
US5387617A (en) *	1993-01-22	1995-02-07	The Dow Chemical Company	Small cell foams and blends and a process for their preparation
US6121056A (en) *	1993-02-24	2000-09-19	Dade Behring Inc.	Random detection of antigens with antibodies immobilized on soluble submicron particles
ATE178717T1 (de) *	1993-02-24	1999-04-15	Dade Behring Inc	Immobilisierung von reagenzien für spezifische bindungsassay
US5898005A (en) *	1993-02-24	1999-04-27	Dade Behring Inc.	Rapid detection of analytes with receptors immobilized on soluble submicron particles
FR2703055B1 (fr) *	1993-03-22	1995-07-07	Guerbet Sa	Nouveaux composés polyiodés, leur préparation et leur utilisation en tant que produits de contraste pour la radiologie .
KR100361933B1 (ko)	1993-09-08	2003-02-14	라 졸라 파마슈티칼 컴파니	화학적으로정의된비중합성결합가플랫폼분자및그것의콘주게이트
US7097839B1 (en)	1993-10-26	2006-08-29	Thomas Jefferson University	ST receptor binding compounds and methods of using the same
FI955320A7 (fi) *	1994-03-07	1995-11-24	Univ Michigan	Bioaktiivisia ja/tai kohdennettuja dendriimikonjugaatteja
AU750411B2 (en) *	1994-03-07	2002-07-18	Dendritic Nanotechnologies, Inc.	Bioactive and/or targeted dendrimer conjugates
GB9407812D0 (en) *	1994-04-20	1994-06-15	Nycomed Salutar Inc	Compounds
NL9400880A (nl) *	1994-05-27	1996-01-02	Dsm Nv	Samenstelling bestaande uit een dendrimeer en een in het dendrimeer opgesloten actieve stof, een werkwijze voor de bereiding van een dergelijke samenstelling en een werkwijze voor het vrijstellen van de actieve stof.
NL9401886A (nl) *	1994-05-27	1996-01-02	Dsm Nv	Samenstelling bestaande uit een dendrimeer en een in het dendrimeer opgesloten actieve stof, een werkwijze voor de bereiding van een dergelijke samenstelling en een werkwijze voor het vrijgeven van de actieve stof.
AUPM623994A0 (en) *	1994-06-15	1994-07-07	Biomolecular Research Institute Limited	Antiviral dendrimers
AU4344696A (en) *	1994-12-21	1996-07-10	Novartis Ag	Oligonucleotide-dendrimer conjugates
FR2734268B1 (fr) *	1995-05-19	1997-07-04	Centre Nat Rech Scient	Nouveaux dendrimeres fonctionnels a terminaisons phosphorees et leur procede de preparation
US6051429A (en)	1995-06-07	2000-04-18	Life Technologies, Inc.	Peptide-enhanced cationic lipid transfections
US6083708A (en) *	1995-08-11	2000-07-04	Dade Behring Inc.	Polypeptide: dendrimer complexes
US5658574A (en) *	1995-10-13	1997-08-19	Chesebrough-Pond's Usa Co., Division Of Conopco, Inc.	Cleansing compositions with dendrimers as mildness agents
NL1001753C2 (nl) *	1995-11-28	1997-05-30	Dsm Nv	Samenstelling omvattende een kunststof en een additief.
DE19625982A1 (de) *	1996-06-28	1998-01-02	Wella Ag	Kosmetisches Mittel zur Haarbehandlung mit Dendrimeren
EP0951486B1 (en) *	1997-01-13	2006-01-11	The Dow Chemical Company	Nanocomposites of dendritic polymers
WO1998056427A1 (fr) *	1997-06-12	1998-12-17	Mitsubishi Chemical Corporation	Agent de contrast
DE19728954C1 (de) *	1997-06-30	1999-04-22	Schering Ag	Saccharid-Konjugate, diese enthaltende pharmazeutische Mittel, Verfahren zu ihrer Herstellung und ihre Verwendung
FR2790642A1 (fr) *	1999-03-08	2000-09-15	Aventis Cropscience Sa	Nouvelles compositions pesticides et/ou regulatrices de croissance
CA2376619A1 (en) *	1999-06-29	2001-01-11	Dako A/S	Detection using dendrimers bearing labels and probes
YU6502A (sh)	1999-07-29	2005-06-10	Epix Medical Inc.	Usmeravanje multimernih agenasa za dobijanje kontrasta pri dijagnostičkom snimanju putem multilokusnog vezivanja
FI19991705A7 (fi) *	1999-08-11	2001-02-12	Neste Chemicals Oy	Antimikrobinen hyperhaaroittunut polymeerikoostumus
FR2797563A1 (fr) *	1999-08-18	2001-02-23	Rhodianyl	Composes biocides et leur utilisation dans des polymeres thermoplastiques
AU784130B2 (en) *	1999-12-10	2006-02-09	Gerald M. Rosen	Use of poly-nitroxyl-functionalized dendrimers as contrast enhancing agents in MRI imaging of joints
DE60131260T2 (de)	2000-04-07	2008-08-28	Shell Internationale Research Maatschappij B.V.	Verfahren zur hemmung von verstopfung von röhren durch gashydrate
US6471968B1 (en) *	2000-05-12	2002-10-29	Regents Of The University Of Michigan	Multifunctional nanodevice platform
CU23011A1 (es) *	2000-11-03	2004-12-17	Ct Ingenieria Genetica Biotech	Método de obtención de estructuras antigénicas quemétodo de obtención de estructuras antigénicas que potencian la reactividad cruzada específica y su potencian la reactividad cruzada específica y su uso en formulaciones uso en formulaciones
EP1401988B1 (en)	2001-06-14	2008-06-04	Shell Internationale Researchmaatschappij B.V.	Method for solubilising asphaltenes in a hydrocarbon mixture
TWI221406B (en)	2001-07-30	2004-10-01	Epix Medical Inc	Systems and methods for targeted magnetic resonance imaging of the vascular system
GB0209022D0 (en)	2002-04-19	2002-05-29	Imp College Innovations Ltd	Compounds
AU2003264262B2 (en)	2002-09-03	2007-10-25	Shell Internationale Research Maatschappij B.V.	Method and compositions for inhibiting formation of hydrocarbon hydrates
EP1525890A1 (en)	2003-10-02	2005-04-27	Complex Biosystems GmbH	Protein-Proteophore complexes
WO2005051295A2 (en) *	2003-11-21	2005-06-09	Anp Technologies, Inc.	Asymmetrically branched polymer conjugates and microarray assays
US7985424B2 (en)	2004-04-20	2011-07-26	Dendritic Nanotechnologies Inc.	Dendritic polymers with enhanced amplification and interior functionality
WO2006065266A2 (en) *	2004-04-20	2006-06-22	Dendritic Nanotechnologies, Inc.	Dendritic polymers with enhanced amplification and interior functionality
KR100844308B1 (ko)	2004-08-13	2008-07-07	닛뽕소다 가부시키가이샤	다분기 폴리머 및 그 제조 방법
AU2005287375B8 (en) *	2004-08-25	2009-11-12	The Regents Of The University Of Michigan	Dendrimer based compositions and methods of using the same
DE602005006704D1 (de)	2004-11-08	2008-06-26	Fujifilm Corp	Verwendung eines Mittels zur Beseitigung vom Sauerstoff
BRPI0518254A2 (pt)	2004-11-24	2008-11-11	Shell Int Research	mÉtodo para melhorar a escoabilidade de uma mistura que contÉm cera e outros hidrocarbonetos, e, mistura de hidrocarboneto contendo cera e outros hidrocarbonetos
JP2008545621A (ja) *	2005-04-20	2008-12-18	デンドリティックナノテクノロジーズ，インコーポレイテッド	強化された拡大性と内部官能基性をもった樹枝状ポリマー
US7575687B2 (en) *	2005-08-16	2009-08-18	Ge Osmonics, Inc.	Membranes and methods useful for caustic applications
US8436103B2 (en)	2005-09-07	2013-05-07	Nippon Soda Co., Ltd.	Star polymer and method of producing the same
EP2676691B1 (en)	2005-11-17	2016-07-06	Zogenix, Inc.	Delivery of viscous formulations by needle-free injection
JP5420902B2 (ja)	2006-07-11	2014-02-19	日本曹達株式会社	スターポリマー及びその製造方法
US20080020043A1 (en) *	2006-07-20	2008-01-24	Marc Gingras	Dendrimer-Drug Conjugates
US8268347B1 (en)	2006-10-24	2012-09-18	Aradigm Corporation	Dual action, inhaled formulations providing both an immediate and sustained release profile
US8658148B2 (en)	2007-06-22	2014-02-25	Genzyme Corporation	Chemically modified dendrimers
KR101176813B1 (ko)	2007-08-31	2012-08-24	닛뽕소다 가부시키가이샤	스타 폴리머의 제조 방법
US8252834B2 (en)	2008-03-12	2012-08-28	The Regents Of The University Of Michigan	Dendrimer conjugates
EP3000462A1 (en)	2008-04-28	2016-03-30	Zogenix, Inc.	Novel formulations for treatment of migraine
US8889635B2 (en)	2008-09-30	2014-11-18	The Regents Of The University Of Michigan	Dendrimer conjugates
WO2010054321A2 (en)	2008-11-07	2010-05-14	The Regents Of The University Of Michigan	Methods of treating autoimmune disorders and/or inflammatory disorders
US8945508B2 (en)	2009-10-13	2015-02-03	The Regents Of The University Of Michigan	Dendrimer compositions and methods of synthesis
JP5997050B2 (ja) *	2009-10-26	2016-09-21	デンドリティックナノテクノロジーズ，インコーポレイテッド	農業における使用のためのｐｅｈａｍデンドリマー
US8912323B2 (en)	2009-10-30	2014-12-16	The Regents Of The University Of Michigan	Multifunctional small molecules
JP5835741B2 (ja)	2010-02-26	2015-12-24	国立大学法人長崎大学	抗原または薬物送達複合体
WO2013085718A1 (en)	2011-12-08	2013-06-13	The Regents Of The University Of Michigan	Multifunctional small molecules
US9921205B2 (en)	2012-11-13	2018-03-20	Chevron U.S.A. Inc.	Method for determining the effectiveness of asphaltene dispersant additives for inhibiting or preventing asphaltene precipitation in a hydrocarbon-containing material subjected to elevated temperature and presssure conditions
GB201405660D0 (en) *	2014-03-28	2014-05-14	Gama Healthcare Ltd	A liquid disinfecting composition
CN108884018B (zh) *	2015-12-16	2021-08-31	优星私人有限公司	树枝状聚合物和其制剂
US10907473B2 (en)	2017-11-14	2021-02-02	Chevron U.S.A., Inc.	Low volume in-line filtration methods for analyzing hydrocarbon-containing fluid to evaluate asphaltene content and behavior during production operations
CN109287624A (zh) *	2018-10-08	2019-02-01	威海晨源分子新材料有限公司	一种树枝状聚酰胺-胺在农药中的应用
WO2020142664A1 (en)	2019-01-03	2020-07-09	Ionpath, Inc.	Compositions and reagents for ion beam imaging
CN114292217A (zh) *	2021-12-31	2022-04-08	安源基因科技(上海)有限公司	生物活性交联剂、生物交联物、试剂盒及应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4289872A (en) *	1979-04-06	1981-09-15	Allied Corporation	Macromolecular highly branched homogeneous compound based on lysine units
IL64277A0 (en) *	1981-11-11	1982-02-28	Basht Ltd	Apparatus for removal of integrated circuits from circuit boards
CA1225930A (en) *	1982-06-07	1987-08-25	Otto A. Gansow	Metal chelate conjugated monoclonal antibodies
US4472509A (en) *	1982-06-07	1984-09-18	Gansow Otto A	Metal chelate conjugated monoclonal antibodies
US4507466A (en) *	1983-01-07	1985-03-26	The Dow Chemical Corporation	Dense star polymers having core, core branches, terminal groups
US4631337A (en) *	1983-01-07	1986-12-23	The Dow Chemical Company	Hydrolytically-stable dense star polyamine
US4558120A (en) *	1983-01-07	1985-12-10	The Dow Chemical Company	Dense star polymer
US4606907A (en) *	1984-07-02	1986-08-19	The Dow Chemical Company	Bone seeking Tc-99m complexes of phosphonate derivatives of polyamidoamines
US4599400A (en) *	1984-12-18	1986-07-08	The Dow Chemical Company	Star/comb-branched polyamide
US4694064A (en) *	1986-02-28	1987-09-15	The Dow Chemical Company	Rod-shaped dendrimer

1987
- 1987-08-17 ES ES87307266T patent/ES2054678T5/es not_active Expired - Lifetime
- 1987-08-17 AT AT87307266T patent/ATE89743T1/de not_active IP Right Cessation
- 1987-08-17 DE DE3786000T patent/DE3786000T3/de not_active Expired - Lifetime
- 1987-08-17 EP EP87307266A patent/EP0271180B2/en not_active Expired - Lifetime
- 1987-08-17 IL IL83567A patent/IL83567A/xx not_active IP Right Cessation
- 1987-08-18 KR KR1019880700411A patent/KR970011151B1/ko not_active Expired - Lifetime
- 1987-08-18 WO PCT/US1987/002076 patent/WO1988001180A1/en unknown
- 1987-08-18 NZ NZ221484A patent/NZ221484A/xx unknown
- 1987-08-18 JP JP62505281A patent/JPH0757736B2/ja not_active Expired - Fee Related
- 1987-08-18 JP JP62505084A patent/JPH0757735B2/ja not_active Expired - Fee Related
- 1987-08-18 JP JP62505282A patent/JPH072840B2/ja not_active Expired - Lifetime
- 1987-08-18 WO PCT/US1987/002075 patent/WO1988001179A1/en active IP Right Grant
- 1987-08-18 MX MX007801A patent/MX169992B/es unknown
- 1987-08-18 BR BR8707433A patent/BR8707433A/pt not_active Application Discontinuation
- 1987-08-18 BR BR8707432A patent/BR8707432A/pt not_active Application Discontinuation
- 1987-08-18 AU AU77159/87A patent/AU609051B2/en not_active Expired
- 1987-08-18 WO PCT/US1987/002074 patent/WO1988001178A1/en unknown
- 1987-08-18 IE IE221087A patent/IE61356B1/en not_active IP Right Cessation
- 1987-08-18 MY MYPI87001361A patent/MY102878A/en unknown
- 1987-08-18 HU HU874562A patent/HU209252B/hu unknown
- 1987-08-18 BR BR8707431A patent/BR8707431A/pt not_active IP Right Cessation
- 1987-08-18 ZA ZA876114A patent/ZA876114B/xx unknown
- 1987-08-18 HU HU9303379A patent/HU220205B/hu unknown
1988
- 1988-04-14 DK DK198802053A patent/DK174053B1/da not_active IP Right Cessation
- 1988-04-15 NO NO881639A patent/NO176306C/no not_active IP Right Cessation
- 1988-04-15 FI FI881768A patent/FI103410B1/fi not_active IP Right Cessation
1991
- 1991-07-26 AU AU81391/91A patent/AU638153B2/en not_active Expired
1992
- 1992-10-14 JP JP4301798A patent/JP2771404B2/ja not_active Expired - Lifetime
1993
- 1993-10-27 JP JP5291283A patent/JP2848218B2/ja not_active Expired - Lifetime
- 1993-10-27 JP JP5291286A patent/JPH07108860B2/ja not_active Expired - Lifetime
1996
- 1996-03-28 HK HK54396A patent/HK54396A/en not_active IP Right Cessation
1997
- 1997-07-23 GR GR970401861T patent/GR3024215T3/el unknown
1998
- 1998-08-24 FI FI981807A patent/FI105693B/fi not_active IP Right Cessation

Also Published As

Publication number	Publication date
ATE89743T1 (de)	1993-06-15
NO176306B (no)	1994-12-05
JPH0757735B2 (ja)	1995-06-21
FI105693B (fi)	2000-09-29
KR970011151B1 (ko)	1997-07-07
JPH069778A (ja)	1994-01-18
JPS63501876A (ja)	1988-07-28
IE61356B1 (en)	1994-11-02
JPH06219966A (ja)	1994-08-09
IE872210L (en)	1988-02-18
WO1988001178A1 (en)	1988-02-25
HU209252B (en)	1994-04-28
FI881768A0 (fi)	1988-04-15
FI103410B (fi)	1999-06-30
IL83567A (en)	1992-02-16
HUT55245A (en)	1991-05-28
JPH0757736B2 (ja)	1995-06-21
DE3786000D1 (de)	1993-07-01
HU220205B (hu)	2001-11-28
DE3786000T3 (de)	1997-08-21
MY102878A (en)	1993-03-31
FI981807A0 (fi)	1998-08-24
WO1988001180A1 (en)	1988-02-25
DK174053B1 (da)	2002-05-13
DE3786000T2 (de)	1993-09-02
IL83567A0 (en)	1988-01-31
BR8707433A (pt)	1988-11-01
AU609051B2 (en)	1991-04-26
EP0271180B2 (en)	1997-06-18
ES2054678T3 (es)	1994-08-16
BR8707431A (pt)	1988-11-01
FI981807L (fi)	1998-08-24
NO881639D0 (no)	1988-04-15
JP2848218B2 (ja)	1999-01-20
AU638153B2 (en)	1993-06-17
JPH06220190A (ja)	1994-08-09
FI103410B1 (fi)	1999-06-30
JPS63501878A (ja)	1988-07-28
JPH072840B2 (ja)	1995-01-18
ES2054678T5 (es)	1997-09-16
DK205388A (da)	1988-06-14
JPS63502350A (ja)	1988-09-08
EP0271180A1 (en)	1988-06-15
MX169992B (es)	1993-08-04
NZ221484A (en)	1991-01-29
HU9303379D0 (en)	1994-03-28
NO176306C (no)	1995-03-15
BR8707432A (pt)	1988-11-01
JPH07108860B2 (ja)	1995-11-22
JP2771404B2 (ja)	1998-07-02
ZA876114B (en)	1989-04-26
AU8139191A (en)	1991-10-03
NO881639L (no)	1988-06-15
EP0271180B1 (en)	1993-05-26
WO1988001179A1 (en)	1988-02-25
HK54396A (en)	1996-04-03
AU7715987A (en)	1988-03-03
GR3024215T3 (en)	1997-10-31
FI881768L (fi)	1988-04-15
DK205388D0 (da)	1988-04-14

Publication	Publication Date	Title
KR880701564A (ko)	1988-11-03	스타버스트 콘쥬게이트
DE68904101D1 (de)	1993-02-11	Polymerzusammensetzungen.
DE58906372D1 (de)	1994-01-20	Polymermischungen.
FI893410L (fi)	1990-01-14	Tvaerbindbar silylpolymerkomposition.
NO891982D0 (no)	1989-05-18	Polymer-sammensetning.
FI910123A0 (fi)	1991-01-09	Polymerkomposition foer att avlaegsna syre.
ATE88898T1 (de)	1993-05-15	Cd4-polypeptidderivate.
DE68906762D1 (de)	1993-07-01	Prostaglandin-polysaccharid-konjugat.
DE68920021D1 (de)	1995-01-26	Polymerzusammensetzung.
DE58902894D1 (de)	1993-01-14	Polymermischungen.
FI893411L (fi)	1990-01-14	Tvaerbindbar silylpolymerkomposition.
FI881526L (fi)	1988-10-03	Tvaerbundbar silylpolymerkomposition.
DE69013796D1 (de)	1994-12-08	Propylen-Polymer-Zusammensetzung.
DE69013711D1 (de)	1994-12-08	Polymerzusammensetzung.
DE68916717D1 (de)	1994-08-18	Selbstverlöschende Polymer-Zusammensetzung.
FI874215A0 (fi)	1987-09-25	Polymermodifierade, omaettade polyester- eller polyesteramidhartser och ur dessa framstaelld polymerbetong.
DE3882313D1 (de)	1993-08-19	Polymerzusammensetzung.
DE69010556D1 (de)	1994-08-18	Polyketonpolymerzusammensetzungen.
DE68915561D1 (de)	1994-07-07	Polymerisierbare Zusammensetzung und Polymer, hergestellt aus dieser.
NO905336L (no)	1990-12-10	Fotonedbrytbar polymersammensetning.
ATE89747T1 (de)	1993-06-15	Prostaglandin-polysaccharid-konjugat.

Legal Events

Date	Code	Title	Description
1988-04-18	PA0109	Patent application	Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 19880418
1988-11-03	PG1501	Laying open of application
1992-08-18	A201	Request for examination
1992-08-18	PA0201	Request for examination	Patent event code: PA02012R01D Patent event date: 19920818 Comment text: Request for Examination of Application Patent event code: PA02011R01I Patent event date: 19880418 Comment text: Patent Application
1995-11-30	E902	Notification of reason for refusal
1995-11-30	PE0902	Notice of grounds for rejection	Comment text: Notification of reason for refusal Patent event date: 19951130 Patent event code: PE09021S01D
1996-09-10	E902	Notification of reason for refusal
1996-09-10	PE0902	Notice of grounds for rejection	Comment text: Notification of reason for refusal Patent event date: 19960910 Patent event code: PE09021S01D
1997-06-10	G160	Decision to publish patent application
1997-07-07	PG1601	Publication of registration
1997-09-29	E701	Decision to grant or registration of patent right
1997-09-29	PE0701	Decision of registration	Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 19970929
1997-12-19	GRNT	Written decision to grant
1997-12-19	PR0701	Registration of establishment	Comment text: Registration of Establishment Patent event date: 19971219 Patent event code: PR07011E01D
1997-12-19	PR1002	Payment of registration fee	Payment date: 19971219 End annual number: 3 Start annual number: 1
2000-06-13	PR1001	Payment of annual fee	Payment date: 20000614 Start annual number: 4 End annual number: 4
2001-07-05	PR1001	Payment of annual fee	Payment date: 20010706 Start annual number: 5 End annual number: 5
2002-09-19	PR1001	Payment of annual fee	Payment date: 20020923 Start annual number: 6 End annual number: 6
2003-09-25	PR1001	Payment of annual fee	Payment date: 20030926 Start annual number: 7 End annual number: 7
2004-09-16	PR1001	Payment of annual fee	Payment date: 20040917 Start annual number: 8 End annual number: 8
2005-12-16	PR1001	Payment of annual fee	Payment date: 20051219 Start annual number: 9 End annual number: 9
2006-09-15	PR1001	Payment of annual fee	Payment date: 20060918 Start annual number: 10 End annual number: 10
2007-12-14	PR1001	Payment of annual fee	Payment date: 20071217 Start annual number: 11 End annual number: 11
2008-12-16	PR1001	Payment of annual fee	Payment date: 20081217 Start annual number: 12 End annual number: 12
2009-12-04	PR1001	Payment of annual fee	Payment date: 20091207 Start annual number: 13 End annual number: 13
2010-12-13	PR1001	Payment of annual fee	Payment date: 20101214 Start annual number: 14 End annual number: 14
2011-12-20	FPAY	Annual fee payment	Payment date: 20111221 Year of fee payment: 15
2011-12-20	PR1001	Payment of annual fee	Payment date: 20111221 Start annual number: 15 End annual number: 15
2012-07-08	EXPY	Expiration of term
2012-07-08	PC1801	Expiration of term	Termination date: 20130409 Termination category: Expiration of duration